nodes	percent_of_prediction	percent_of_DWPC	metapath
Fondaparinux sodium—F10—Extrinsic Pathway—F9—prostate cancer	0.0284	0.0946	CbGpPWpGaD
Fondaparinux sodium—F10—Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus—F9—prostate cancer	0.0195	0.0649	CbGpPWpGaD
Fondaparinux sodium—F10—Removal of aminoterminal propeptides from gamma-carboxylated proteins—F9—prostate cancer	0.0177	0.0591	CbGpPWpGaD
Fondaparinux sodium—F10—Gamma-carboxylation of protein precursors—F9—prostate cancer	0.0177	0.0591	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Intrinsic Pathway—F9—prostate cancer	0.0154	0.0512	CbGpPWpGaD
Fondaparinux sodium—F10—Gamma-carboxylation, transport, and amino-terminal cleavage of proteins—F9—prostate cancer	0.0151	0.0503	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Formation of Fibrin Clot (Clotting Cascade)—F9—prostate cancer	0.0104	0.0345	CbGpPWpGaD
Fondaparinux sodium—F10—Beta2 integrin cell surface interactions—SPON2—prostate cancer	0.0102	0.034	CbGpPWpGaD
Fondaparinux sodium—F10—Blood Clotting Cascade—F9—prostate cancer	0.00867	0.0289	CbGpPWpGaD
Fondaparinux sodium—F10—Intrinsic Pathway—F9—prostate cancer	0.00867	0.0289	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—PRNP—prostate cancer	0.00797	0.0265	CbGpPWpGaD
Fondaparinux sodium—F10—PTM: gamma carboxylation, hypusine formation and arylsulfatase activation—F9—prostate cancer	0.00715	0.0238	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—F9—prostate cancer	0.00697	0.0232	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—TGFBR1—prostate cancer	0.00677	0.0226	CbGpPWpGaD
Fondaparinux sodium—F10—Formation of Fibrin Clot (Clotting Cascade)—F9—prostate cancer	0.00585	0.0195	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—TGFBR2—prostate cancer	0.0048	0.016	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—CLU—prostate cancer	0.00464	0.0155	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—F9—prostate cancer	0.00394	0.0131	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—FGF2—prostate cancer	0.00276	0.00919	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—PLAUR—prostate cancer	0.00273	0.00909	CbGpPWpGaD
Fondaparinux sodium—F10—Beta2 integrin cell surface interactions—PLAUR—prostate cancer	0.00272	0.00906	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—CLU—prostate cancer	0.00262	0.00874	CbGpPWpGaD
Fondaparinux sodium—F10—Blood Clotting Cascade—PLAU—prostate cancer	0.00238	0.00793	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—TUSC3—prostate cancer	0.0021	0.00701	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—SRC—prostate cancer	0.00201	0.00671	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—HBG1—prostate cancer	0.002	0.00667	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—VEGFA—prostate cancer	0.00196	0.00653	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—PLAU—prostate cancer	0.00191	0.00637	CbGpPWpGaD
Fondaparinux sodium—F10—Beta2 integrin cell surface interactions—PLAU—prostate cancer	0.00191	0.00636	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—GALNT3—prostate cancer	0.00188	0.00625	CbGpPWpGaD
Fondaparinux sodium—F10—Blood Clotting Cascade—SERPINE1—prostate cancer	0.00184	0.00613	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—TGFB1—prostate cancer	0.0018	0.006	CbGpPWpGaD
Fondaparinux sodium—F10—Beta2 integrin cell surface interactions—ICAM1—prostate cancer	0.00177	0.00589	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—SPON2—prostate cancer	0.00172	0.00572	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—HBG2—prostate cancer	0.0017	0.00567	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—TMSB4X—prostate cancer	0.0017	0.00567	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—PLAUR—prostate cancer	0.00154	0.00513	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—RPN2—prostate cancer	0.0015	0.005	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—SERPINE1—prostate cancer	0.00148	0.00493	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—RAD51B—prostate cancer	0.00139	0.00463	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—STX4—prostate cancer	0.00139	0.00463	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—GCNT1—prostate cancer	0.0013	0.00433	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—PDIA3—prostate cancer	0.00125	0.00417	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—F9—prostate cancer	0.00125	0.00416	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—B4GALT4—prostate cancer	0.00121	0.00403	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—F9—prostate cancer	0.00117	0.0039	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—HBG1—prostate cancer	0.00113	0.00377	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—MUC4—prostate cancer	0.00111	0.00368	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—PLAU—prostate cancer	0.00108	0.0036	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—TUSC3—prostate cancer	0.000999	0.00333	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—IGFBP6—prostate cancer	0.000999	0.00333	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—ITGA6—prostate cancer	0.000978	0.00326	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—HBG2—prostate cancer	0.000962	0.00321	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—TMSB4X—prostate cancer	0.000962	0.00321	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—CD9—prostate cancer	0.000919	0.00306	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—GALNT3—prostate cancer	0.00089	0.00297	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—SSR2—prostate cancer	0.00089	0.00297	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—SERPINE1—prostate cancer	0.000836	0.00279	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—CLU—prostate cancer	0.000831	0.00277	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—SPON2—prostate cancer	0.000814	0.00271	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—HERPUD1—prostate cancer	0.000814	0.00271	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—STX4—prostate cancer	0.000784	0.00261	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—RAD51B—prostate cancer	0.000784	0.00261	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—GRB7—prostate cancer	0.00076	0.00253	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—KLK3—prostate cancer	0.000757	0.00252	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—GNG5—prostate cancer	0.000723	0.00241	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—KLK2—prostate cancer	0.000712	0.00237	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—RPN2—prostate cancer	0.000712	0.00237	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—MBTPS1—prostate cancer	0.000712	0.00237	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—F9—prostate cancer	0.000706	0.00235	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—TCP1—prostate cancer	0.000674	0.00225	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—DNAJC3—prostate cancer	0.000643	0.00214	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—GCNT1—prostate cancer	0.000617	0.00206	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PRKACB—prostate cancer	0.000617	0.00206	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—THBS1—prostate cancer	0.000601	0.002	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—PDIA3—prostate cancer	0.000594	0.00198	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PRKCZ—prostate cancer	0.000582	0.00194	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—EIF3H—prostate cancer	0.000574	0.00191	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—B4GALT4—prostate cancer	0.000574	0.00191	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—TPP1—prostate cancer	0.000574	0.00191	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—THBS1—prostate cancer	0.000563	0.00188	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—F9—prostate cancer	0.000555	0.00185	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—ITGA6—prostate cancer	0.000553	0.00184	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—CALR—prostate cancer	0.000535	0.00178	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—MUC4—prostate cancer	0.000525	0.00175	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—CD9—prostate cancer	0.000519	0.00173	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PRKCQ—prostate cancer	0.000494	0.00165	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PLAUR—prostate cancer	0.000489	0.00163	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—CLU—prostate cancer	0.00047	0.00157	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—RPL12—prostate cancer	0.000458	0.00153	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—PLAUR—prostate cancer	0.000458	0.00153	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—VAV3—prostate cancer	0.000453	0.00151	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—ITPR1—prostate cancer	0.00044	0.00147	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—HSP90B1—prostate cancer	0.000435	0.00145	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—GRB7—prostate cancer	0.00043	0.00143	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—EIF3A—prostate cancer	0.000421	0.0014	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—GNG5—prostate cancer	0.000409	0.00136	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—ITGB3—prostate cancer	0.000389	0.0013	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—MME—prostate cancer	0.000374	0.00125	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—GRP—prostate cancer	0.000358	0.00119	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PRKACB—prostate cancer	0.000348	0.00116	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—RPL10—prostate cancer	0.000347	0.00116	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PLAU—prostate cancer	0.000343	0.00114	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—THBS1—prostate cancer	0.00034	0.00113	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—CAV1—prostate cancer	0.000335	0.00112	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PRKCZ—prostate cancer	0.000329	0.0011	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—ATF3—prostate cancer	0.000312	0.00104	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PIK3CG—prostate cancer	0.000305	0.00102	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—EGF—prostate cancer	0.000301	0.001	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—IGFBP3—prostate cancer	0.000294	0.000978	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—ACHE—prostate cancer	0.000287	0.000955	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—CREBBP—prostate cancer	0.000283	0.000942	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PRKCQ—prostate cancer	0.000279	0.000931	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—IGF1—prostate cancer	0.000279	0.00093	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PLAUR—prostate cancer	0.000276	0.00092	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—RPS19—prostate cancer	0.000276	0.000918	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—CTSD—prostate cancer	0.000271	0.000904	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PIK3CD—prostate cancer	0.000268	0.000893	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—THBS1—prostate cancer	0.000267	0.00089	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—SERPINE1—prostate cancer	0.000265	0.000884	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—VAV3—prostate cancer	0.000256	0.000854	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—CALR—prostate cancer	0.000254	0.000846	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—NOS3—prostate cancer	0.000253	0.000844	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—ITPR1—prostate cancer	0.000248	0.000828	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—JAK2—prostate cancer	0.000246	0.00082	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—ACE—prostate cancer	0.000242	0.000806	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PIK3CB—prostate cancer	0.000234	0.000779	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—ITGB3—prostate cancer	0.00022	0.000733	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—PLAUR—prostate cancer	0.000217	0.000724	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—IL2—prostate cancer	0.000215	0.000715	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PLAU—prostate cancer	0.000194	0.000645	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—EP300—prostate cancer	0.000193	0.000642	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—CAV1—prostate cancer	0.000189	0.00063	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—SRC—prostate cancer	0.000187	0.000624	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—VEGFA—prostate cancer	0.000182	0.000608	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PIK3CG—prostate cancer	0.000172	0.000574	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—EGF—prostate cancer	0.00017	0.000568	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—TGFB1—prostate cancer	0.000167	0.000558	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—CREBBP—prostate cancer	0.00016	0.000532	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—IGF1—prostate cancer	0.000158	0.000526	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—KRAS—prostate cancer	0.000155	0.000517	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PIK3CD—prostate cancer	0.000151	0.000505	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—LEP—prostate cancer	0.00015	0.000501	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—SERPINE1—prostate cancer	0.00015	0.000499	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—NOS3—prostate cancer	0.000143	0.000477	CbGpPWpGaD
Fondaparinux sodium—Infestation—Doxorubicin—prostate cancer	0.000143	0.000204	CcSEcCtD
Fondaparinux sodium—Dermatitis—Estradiol—prostate cancer	0.000142	0.000203	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—PIK3CA—prostate cancer	0.000142	0.000475	CbGpPWpGaD
Fondaparinux sodium—Anaemia—Prednisone—prostate cancer	0.000142	0.000203	CcSEcCtD
Fondaparinux sodium—Confusional state—Capecitabine—prostate cancer	0.000142	0.000203	CcSEcCtD
Fondaparinux sodium—Tachycardia—Docetaxel—prostate cancer	0.000142	0.000203	CcSEcCtD
Fondaparinux sodium—Headache—Estradiol—prostate cancer	0.000142	0.000202	CcSEcCtD
Fondaparinux sodium—Skin disorder—Docetaxel—prostate cancer	0.000141	0.000202	CcSEcCtD
Fondaparinux sodium—Oedema—Capecitabine—prostate cancer	0.000141	0.000201	CcSEcCtD
Fondaparinux sodium—Angioedema—Prednisone—prostate cancer	0.000141	0.000201	CcSEcCtD
Fondaparinux sodium—Renal failure—Doxorubicin—prostate cancer	0.00014	0.0002	CcSEcCtD
Fondaparinux sodium—Infection—Capecitabine—prostate cancer	0.00014	0.0002	CcSEcCtD
Fondaparinux sodium—Urticaria—Etoposide—prostate cancer	0.000139	0.000199	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—JAK2—prostate cancer	0.000139	0.000463	CbGpPWpGaD
Fondaparinux sodium—Haemoglobin—Epirubicin—prostate cancer	0.000139	0.000199	CcSEcCtD
Fondaparinux sodium—Anorexia—Docetaxel—prostate cancer	0.000139	0.000198	CcSEcCtD
Fondaparinux sodium—Shock—Capecitabine—prostate cancer	0.000139	0.000198	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Etoposide—prostate cancer	0.000139	0.000198	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Etoposide—prostate cancer	0.000139	0.000198	CcSEcCtD
Fondaparinux sodium—Urinary tract infection—Doxorubicin—prostate cancer	0.000139	0.000198	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Capecitabine—prostate cancer	0.000138	0.000198	CcSEcCtD
Fondaparinux sodium—Vertigo—Prednisone—prostate cancer	0.000138	0.000198	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Epirubicin—prostate cancer	0.000138	0.000198	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Capecitabine—prostate cancer	0.000138	0.000197	CcSEcCtD
Fondaparinux sodium—Syncope—Prednisone—prostate cancer	0.000138	0.000197	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—TP53—prostate cancer	0.000138	0.000459	CbGpPWpGaD
Fondaparinux sodium—Tachycardia—Capecitabine—prostate cancer	0.000138	0.000197	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Epirubicin—prostate cancer	0.000138	0.000197	CcSEcCtD
Fondaparinux sodium—Skin disorder—Capecitabine—prostate cancer	0.000137	0.000196	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Capecitabine—prostate cancer	0.000136	0.000195	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Epirubicin—prostate cancer	0.000136	0.000195	CcSEcCtD
Fondaparinux sodium—Hypotension—Docetaxel—prostate cancer	0.000136	0.000194	CcSEcCtD
Fondaparinux sodium—Haematuria—Doxorubicin—prostate cancer	0.000136	0.000194	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Prednisone—prostate cancer	0.000135	0.000193	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Doxorubicin—prostate cancer	0.000135	0.000193	CcSEcCtD
Fondaparinux sodium—Epistaxis—Doxorubicin—prostate cancer	0.000134	0.000192	CcSEcCtD
Fondaparinux sodium—Anorexia—Capecitabine—prostate cancer	0.000134	0.000192	CcSEcCtD
Fondaparinux sodium—Nausea—Estradiol—prostate cancer	0.000134	0.000192	CcSEcCtD
Fondaparinux sodium—Vomiting—Mitoxantrone—prostate cancer	0.000134	0.000191	CcSEcCtD
Fondaparinux sodium—Convulsion—Prednisone—prostate cancer	0.000133	0.00019	CcSEcCtD
Fondaparinux sodium—Rash—Mitoxantrone—prostate cancer	0.000133	0.00019	CcSEcCtD
Fondaparinux sodium—Dermatitis—Mitoxantrone—prostate cancer	0.000133	0.00019	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—PIK3CB—prostate cancer	0.000132	0.00044	CbGpPWpGaD
Fondaparinux sodium—Headache—Mitoxantrone—prostate cancer	0.000132	0.000189	CcSEcCtD
Fondaparinux sodium—Hypotension—Capecitabine—prostate cancer	0.000132	0.000188	CcSEcCtD
Fondaparinux sodium—Insomnia—Docetaxel—prostate cancer	0.000132	0.000188	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Docetaxel—prostate cancer	0.000131	0.000187	CcSEcCtD
Fondaparinux sodium—Anxiety—Prednisone—prostate cancer	0.000131	0.000187	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.00013	0.000186	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Docetaxel—prostate cancer	0.00013	0.000185	CcSEcCtD
Fondaparinux sodium—Somnolence—Docetaxel—prostate cancer	0.000129	0.000185	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Etoposide—prostate cancer	0.000129	0.000184	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Doxorubicin—prostate cancer	0.000129	0.000184	CcSEcCtD
Fondaparinux sodium—Flushing—Epirubicin—prostate cancer	0.000128	0.000183	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—INS—prostate cancer	0.000128	0.000428	CbGpPWpGaD
Fondaparinux sodium—Dyspepsia—Docetaxel—prostate cancer	0.000128	0.000183	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Doxorubicin—prostate cancer	0.000128	0.000183	CcSEcCtD
Fondaparinux sodium—Insomnia—Capecitabine—prostate cancer	0.000128	0.000182	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Doxorubicin—prostate cancer	0.000127	0.000182	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Capecitabine—prostate cancer	0.000127	0.000181	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Docetaxel—prostate cancer	0.000127	0.000181	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Doxorubicin—prostate cancer	0.000126	0.00018	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000126	0.00018	CcSEcCtD
Fondaparinux sodium—Asthenia—Etoposide—prostate cancer	0.000126	0.00018	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Capecitabine—prostate cancer	0.000126	0.00018	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Prednisone—prostate cancer	0.000126	0.000179	CcSEcCtD
Fondaparinux sodium—Oedema—Prednisone—prostate cancer	0.000126	0.000179	CcSEcCtD
Fondaparinux sodium—Fatigue—Docetaxel—prostate cancer	0.000126	0.000179	CcSEcCtD
Fondaparinux sodium—Angiopathy—Epirubicin—prostate cancer	0.000125	0.000179	CcSEcCtD
Fondaparinux sodium—Nausea—Mitoxantrone—prostate cancer	0.000125	0.000179	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Epirubicin—prostate cancer	0.000125	0.000178	CcSEcCtD
Fondaparinux sodium—Infection—Prednisone—prostate cancer	0.000125	0.000178	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Epirubicin—prostate cancer	0.000125	0.000178	CcSEcCtD
Fondaparinux sodium—Pain—Docetaxel—prostate cancer	0.000125	0.000178	CcSEcCtD
Fondaparinux sodium—Constipation—Docetaxel—prostate cancer	0.000125	0.000178	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Capecitabine—prostate cancer	0.000124	0.000177	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—IGF1—prostate cancer	0.000124	0.000414	CbGpPWpGaD
Fondaparinux sodium—Pruritus—Etoposide—prostate cancer	0.000124	0.000177	CcSEcCtD
Fondaparinux sodium—Shock—Prednisone—prostate cancer	0.000124	0.000177	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Epirubicin—prostate cancer	0.000124	0.000176	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Prednisone—prostate cancer	0.000123	0.000176	CcSEcCtD
Fondaparinux sodium—Tachycardia—Prednisone—prostate cancer	0.000123	0.000175	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Capecitabine—prostate cancer	0.000123	0.000175	CcSEcCtD
Fondaparinux sodium—Skin disorder—Prednisone—prostate cancer	0.000122	0.000174	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000122	0.000174	CcSEcCtD
Fondaparinux sodium—Fatigue—Capecitabine—prostate cancer	0.000122	0.000174	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Prednisone—prostate cancer	0.000121	0.000173	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—IL2—prostate cancer	0.000121	0.000404	CbGpPWpGaD
Fondaparinux sodium—Constipation—Capecitabine—prostate cancer	0.000121	0.000172	CcSEcCtD
Fondaparinux sodium—Pain—Capecitabine—prostate cancer	0.000121	0.000172	CcSEcCtD
Fondaparinux sodium—Malnutrition—Epirubicin—prostate cancer	0.00012	0.000172	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—MMP2—prostate cancer	0.00012	0.0004	CbGpPWpGaD
Fondaparinux sodium—Feeling abnormal—Docetaxel—prostate cancer	0.00012	0.000171	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Etoposide—prostate cancer	0.00012	0.000171	CcSEcCtD
Fondaparinux sodium—Anorexia—Prednisone—prostate cancer	0.00012	0.000171	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Docetaxel—prostate cancer	0.000119	0.00017	CcSEcCtD
Fondaparinux sodium—Flushing—Doxorubicin—prostate cancer	0.000119	0.00017	CcSEcCtD
Fondaparinux sodium—Flatulence—Epirubicin—prostate cancer	0.000119	0.000169	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Epirubicin—prostate cancer	0.000118	0.000168	CcSEcCtD
Fondaparinux sodium—Back pain—Epirubicin—prostate cancer	0.000116	0.000166	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—AKT1—prostate cancer	0.000116	0.000388	CbGpPWpGaD
Fondaparinux sodium—Feeling abnormal—Capecitabine—prostate cancer	0.000116	0.000166	CcSEcCtD
Fondaparinux sodium—Angiopathy—Doxorubicin—prostate cancer	0.000116	0.000166	CcSEcCtD
Fondaparinux sodium—Dizziness—Etoposide—prostate cancer	0.000116	0.000166	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Doxorubicin—prostate cancer	0.000116	0.000165	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Capecitabine—prostate cancer	0.000115	0.000165	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Doxorubicin—prostate cancer	0.000115	0.000165	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Docetaxel—prostate cancer	0.000115	0.000164	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Docetaxel—prostate cancer	0.000115	0.000164	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Doxorubicin—prostate cancer	0.000114	0.000163	CcSEcCtD
Fondaparinux sodium—Insomnia—Prednisone—prostate cancer	0.000114	0.000162	CcSEcCtD
Fondaparinux sodium—Vision blurred—Epirubicin—prostate cancer	0.000113	0.000162	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Prednisone—prostate cancer	0.000113	0.000161	CcSEcCtD
Fondaparinux sodium—Urticaria—Capecitabine—prostate cancer	0.000112	0.00016	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Capecitabine—prostate cancer	0.000111	0.000159	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Capecitabine—prostate cancer	0.000111	0.000159	CcSEcCtD
Fondaparinux sodium—Vomiting—Etoposide—prostate cancer	0.000111	0.000159	CcSEcCtD
Fondaparinux sodium—Malnutrition—Doxorubicin—prostate cancer	0.000111	0.000159	CcSEcCtD
Fondaparinux sodium—Anaemia—Epirubicin—prostate cancer	0.000111	0.000159	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Prednisone—prostate cancer	0.000111	0.000158	CcSEcCtD
Fondaparinux sodium—Rash—Etoposide—prostate cancer	0.00011	0.000158	CcSEcCtD
Fondaparinux sodium—Dermatitis—Etoposide—prostate cancer	0.00011	0.000158	CcSEcCtD
Fondaparinux sodium—Headache—Etoposide—prostate cancer	0.00011	0.000157	CcSEcCtD
Fondaparinux sodium—Flatulence—Doxorubicin—prostate cancer	0.00011	0.000157	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Prednisone—prostate cancer	0.000109	0.000156	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Doxorubicin—prostate cancer	0.000109	0.000156	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—EP300—prostate cancer	0.000109	0.000363	CbGpPWpGaD
Fondaparinux sodium—Fatigue—Prednisone—prostate cancer	0.000108	0.000155	CcSEcCtD
Fondaparinux sodium—Vertigo—Epirubicin—prostate cancer	0.000108	0.000154	CcSEcCtD
Fondaparinux sodium—Syncope—Epirubicin—prostate cancer	0.000108	0.000154	CcSEcCtD
Fondaparinux sodium—Back pain—Doxorubicin—prostate cancer	0.000108	0.000154	CcSEcCtD
Fondaparinux sodium—Constipation—Prednisone—prostate cancer	0.000107	0.000153	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Docetaxel—prostate cancer	0.000107	0.000153	CcSEcCtD
Fondaparinux sodium—Palpitations—Epirubicin—prostate cancer	0.000106	0.000152	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—SRC—prostate cancer	0.000106	0.000353	CbGpPWpGaD
Fondaparinux sodium—Loss of consciousness—Epirubicin—prostate cancer	0.000106	0.000151	CcSEcCtD
Fondaparinux sodium—Cough—Epirubicin—prostate cancer	0.000105	0.00015	CcSEcCtD
Fondaparinux sodium—Vision blurred—Doxorubicin—prostate cancer	0.000105	0.00015	CcSEcCtD
Fondaparinux sodium—Asthenia—Docetaxel—prostate cancer	0.000104	0.000149	CcSEcCtD
Fondaparinux sodium—Convulsion—Epirubicin—prostate cancer	0.000104	0.000149	CcSEcCtD
Fondaparinux sodium—Nausea—Etoposide—prostate cancer	0.000104	0.000149	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Capecitabine—prostate cancer	0.000104	0.000148	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Prednisone—prostate cancer	0.000103	0.000148	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—VEGFA—prostate cancer	0.000103	0.000343	CbGpPWpGaD
Fondaparinux sodium—Pruritus—Docetaxel—prostate cancer	0.000103	0.000147	CcSEcCtD
Fondaparinux sodium—Anaemia—Doxorubicin—prostate cancer	0.000103	0.000147	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Prednisone—prostate cancer	0.000103	0.000147	CcSEcCtD
Fondaparinux sodium—Chest pain—Epirubicin—prostate cancer	0.000102	0.000146	CcSEcCtD
Fondaparinux sodium—Anxiety—Epirubicin—prostate cancer	0.000102	0.000146	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.000102	0.000145	CcSEcCtD
Fondaparinux sodium—Asthenia—Capecitabine—prostate cancer	0.000101	0.000145	CcSEcCtD
Fondaparinux sodium—Vertigo—Doxorubicin—prostate cancer	0.0001	0.000143	CcSEcCtD
Fondaparinux sodium—Syncope—Doxorubicin—prostate cancer	9.99e-05	0.000143	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—CXCL8—prostate cancer	9.98e-05	0.000333	CbGpPWpGaD
Fondaparinux sodium—Urticaria—Prednisone—prostate cancer	9.98e-05	0.000143	CcSEcCtD
Fondaparinux sodium—Pruritus—Capecitabine—prostate cancer	9.98e-05	0.000143	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Docetaxel—prostate cancer	9.96e-05	0.000142	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Prednisone—prostate cancer	9.93e-05	0.000142	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Prednisone—prostate cancer	9.93e-05	0.000142	CcSEcCtD
Fondaparinux sodium—Confusional state—Epirubicin—prostate cancer	9.9e-05	0.000142	CcSEcCtD
Fondaparinux sodium—Palpitations—Doxorubicin—prostate cancer	9.84e-05	0.000141	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Epirubicin—prostate cancer	9.82e-05	0.00014	CcSEcCtD
Fondaparinux sodium—Oedema—Epirubicin—prostate cancer	9.82e-05	0.00014	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Doxorubicin—prostate cancer	9.79e-05	0.00014	CcSEcCtD
Fondaparinux sodium—Infection—Epirubicin—prostate cancer	9.76e-05	0.000139	CcSEcCtD
Fondaparinux sodium—Cough—Doxorubicin—prostate cancer	9.72e-05	0.000139	CcSEcCtD
Fondaparinux sodium—Shock—Epirubicin—prostate cancer	9.66e-05	0.000138	CcSEcCtD
Fondaparinux sodium—Convulsion—Doxorubicin—prostate cancer	9.65e-05	0.000138	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Capecitabine—prostate cancer	9.65e-05	0.000138	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Epirubicin—prostate cancer	9.63e-05	0.000138	CcSEcCtD
Fondaparinux sodium—Dizziness—Docetaxel—prostate cancer	9.63e-05	0.000138	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Epirubicin—prostate cancer	9.62e-05	0.000137	CcSEcCtD
Fondaparinux sodium—Tachycardia—Epirubicin—prostate cancer	9.59e-05	0.000137	CcSEcCtD
Fondaparinux sodium—Skin disorder—Epirubicin—prostate cancer	9.54e-05	0.000136	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Epirubicin—prostate cancer	9.5e-05	0.000136	CcSEcCtD
Fondaparinux sodium—Chest pain—Doxorubicin—prostate cancer	9.48e-05	0.000135	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—TGFB1—prostate cancer	9.46e-05	0.000315	CbGpPWpGaD
Fondaparinux sodium—Anxiety—Doxorubicin—prostate cancer	9.45e-05	0.000135	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	9.42e-05	0.000135	CcSEcCtD
Fondaparinux sodium—Anorexia—Epirubicin—prostate cancer	9.36e-05	0.000134	CcSEcCtD
Fondaparinux sodium—Dizziness—Capecitabine—prostate cancer	9.32e-05	0.000133	CcSEcCtD
Fondaparinux sodium—Vomiting—Docetaxel—prostate cancer	9.26e-05	0.000132	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Prednisone—prostate cancer	9.25e-05	0.000132	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—CTNNB1—prostate cancer	9.21e-05	0.000307	CbGpPWpGaD
Fondaparinux sodium—Rash—Docetaxel—prostate cancer	9.18e-05	0.000131	CcSEcCtD
Fondaparinux sodium—Hypotension—Epirubicin—prostate cancer	9.18e-05	0.000131	CcSEcCtD
Fondaparinux sodium—Dermatitis—Docetaxel—prostate cancer	9.17e-05	0.000131	CcSEcCtD
Fondaparinux sodium—Confusional state—Doxorubicin—prostate cancer	9.16e-05	0.000131	CcSEcCtD
Fondaparinux sodium—Headache—Docetaxel—prostate cancer	9.12e-05	0.00013	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Doxorubicin—prostate cancer	9.09e-05	0.00013	CcSEcCtD
Fondaparinux sodium—Oedema—Doxorubicin—prostate cancer	9.09e-05	0.00013	CcSEcCtD
Fondaparinux sodium—Infection—Doxorubicin—prostate cancer	9.03e-05	0.000129	CcSEcCtD
Fondaparinux sodium—Asthenia—Prednisone—prostate cancer	9.01e-05	0.000129	CcSEcCtD
Fondaparinux sodium—Vomiting—Capecitabine—prostate cancer	8.97e-05	0.000128	CcSEcCtD
Fondaparinux sodium—Shock—Doxorubicin—prostate cancer	8.94e-05	0.000128	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Doxorubicin—prostate cancer	8.91e-05	0.000127	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Doxorubicin—prostate cancer	8.9e-05	0.000127	CcSEcCtD
Fondaparinux sodium—Rash—Capecitabine—prostate cancer	8.89e-05	0.000127	CcSEcCtD
Fondaparinux sodium—Pruritus—Prednisone—prostate cancer	8.89e-05	0.000127	CcSEcCtD
Fondaparinux sodium—Insomnia—Epirubicin—prostate cancer	8.88e-05	0.000127	CcSEcCtD
Fondaparinux sodium—Dermatitis—Capecitabine—prostate cancer	8.88e-05	0.000127	CcSEcCtD
Fondaparinux sodium—Tachycardia—Doxorubicin—prostate cancer	8.87e-05	0.000127	CcSEcCtD
Fondaparinux sodium—Headache—Capecitabine—prostate cancer	8.83e-05	0.000126	CcSEcCtD
Fondaparinux sodium—Skin disorder—Doxorubicin—prostate cancer	8.83e-05	0.000126	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Epirubicin—prostate cancer	8.82e-05	0.000126	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Doxorubicin—prostate cancer	8.79e-05	0.000126	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—KRAS—prostate cancer	8.76e-05	0.000292	CbGpPWpGaD
Fondaparinux sodium—Dyspnoea—Epirubicin—prostate cancer	8.76e-05	0.000125	CcSEcCtD
Fondaparinux sodium—Somnolence—Epirubicin—prostate cancer	8.73e-05	0.000125	CcSEcCtD
Fondaparinux sodium—Anorexia—Doxorubicin—prostate cancer	8.66e-05	0.000124	CcSEcCtD
Fondaparinux sodium—Nausea—Docetaxel—prostate cancer	8.65e-05	0.000124	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Epirubicin—prostate cancer	8.65e-05	0.000124	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Prednisone—prostate cancer	8.59e-05	0.000123	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Epirubicin—prostate cancer	8.54e-05	0.000122	CcSEcCtD
Fondaparinux sodium—Hypotension—Doxorubicin—prostate cancer	8.49e-05	0.000121	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Epirubicin—prostate cancer	8.48e-05	0.000121	CcSEcCtD
Fondaparinux sodium—Fatigue—Epirubicin—prostate cancer	8.47e-05	0.000121	CcSEcCtD
Fondaparinux sodium—Pain—Epirubicin—prostate cancer	8.4e-05	0.00012	CcSEcCtD
Fondaparinux sodium—Constipation—Epirubicin—prostate cancer	8.4e-05	0.00012	CcSEcCtD
Fondaparinux sodium—Nausea—Capecitabine—prostate cancer	8.38e-05	0.00012	CcSEcCtD
Fondaparinux sodium—Dizziness—Prednisone—prostate cancer	8.31e-05	0.000119	CcSEcCtD
Fondaparinux sodium—Insomnia—Doxorubicin—prostate cancer	8.22e-05	0.000117	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Doxorubicin—prostate cancer	8.16e-05	0.000117	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Doxorubicin—prostate cancer	8.1e-05	0.000116	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Epirubicin—prostate cancer	8.09e-05	0.000116	CcSEcCtD
Fondaparinux sodium—Somnolence—Doxorubicin—prostate cancer	8.08e-05	0.000115	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—PIK3CA—prostate cancer	8.05e-05	0.000268	CbGpPWpGaD
Fondaparinux sodium—Gastrointestinal pain—Epirubicin—prostate cancer	8.03e-05	0.000115	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Doxorubicin—prostate cancer	8e-05	0.000114	CcSEcCtD
Fondaparinux sodium—Vomiting—Prednisone—prostate cancer	7.99e-05	0.000114	CcSEcCtD
Fondaparinux sodium—Rash—Prednisone—prostate cancer	7.92e-05	0.000113	CcSEcCtD
Fondaparinux sodium—Dermatitis—Prednisone—prostate cancer	7.91e-05	0.000113	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Doxorubicin—prostate cancer	7.9e-05	0.000113	CcSEcCtD
Fondaparinux sodium—Headache—Prednisone—prostate cancer	7.87e-05	0.000112	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Doxorubicin—prostate cancer	7.85e-05	0.000112	CcSEcCtD
Fondaparinux sodium—Fatigue—Doxorubicin—prostate cancer	7.84e-05	0.000112	CcSEcCtD
Fondaparinux sodium—Urticaria—Epirubicin—prostate cancer	7.8e-05	0.000111	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—TP53—prostate cancer	7.79e-05	0.000259	CbGpPWpGaD
Fondaparinux sodium—Pain—Doxorubicin—prostate cancer	7.77e-05	0.000111	CcSEcCtD
Fondaparinux sodium—Constipation—Doxorubicin—prostate cancer	7.77e-05	0.000111	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Epirubicin—prostate cancer	7.77e-05	0.000111	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Epirubicin—prostate cancer	7.77e-05	0.000111	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Doxorubicin—prostate cancer	7.49e-05	0.000107	CcSEcCtD
Fondaparinux sodium—Nausea—Prednisone—prostate cancer	7.46e-05	0.000107	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Doxorubicin—prostate cancer	7.43e-05	0.000106	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Epirubicin—prostate cancer	7.24e-05	0.000103	CcSEcCtD
Fondaparinux sodium—Urticaria—Doxorubicin—prostate cancer	7.22e-05	0.000103	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Doxorubicin—prostate cancer	7.18e-05	0.000103	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Doxorubicin—prostate cancer	7.18e-05	0.000103	CcSEcCtD
Fondaparinux sodium—Asthenia—Epirubicin—prostate cancer	7.05e-05	0.000101	CcSEcCtD
Fondaparinux sodium—Pruritus—Epirubicin—prostate cancer	6.95e-05	9.93e-05	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Epirubicin—prostate cancer	6.72e-05	9.6e-05	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Doxorubicin—prostate cancer	6.7e-05	9.57e-05	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—AKT1—prostate cancer	6.57e-05	0.000219	CbGpPWpGaD
Fondaparinux sodium—Asthenia—Doxorubicin—prostate cancer	6.52e-05	9.32e-05	CcSEcCtD
Fondaparinux sodium—Dizziness—Epirubicin—prostate cancer	6.5e-05	9.28e-05	CcSEcCtD
Fondaparinux sodium—Pruritus—Doxorubicin—prostate cancer	6.43e-05	9.19e-05	CcSEcCtD
Fondaparinux sodium—Vomiting—Epirubicin—prostate cancer	6.25e-05	8.92e-05	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Doxorubicin—prostate cancer	6.22e-05	8.88e-05	CcSEcCtD
Fondaparinux sodium—Rash—Epirubicin—prostate cancer	6.19e-05	8.85e-05	CcSEcCtD
Fondaparinux sodium—Dermatitis—Epirubicin—prostate cancer	6.19e-05	8.84e-05	CcSEcCtD
Fondaparinux sodium—Headache—Epirubicin—prostate cancer	6.15e-05	8.79e-05	CcSEcCtD
Fondaparinux sodium—Dizziness—Doxorubicin—prostate cancer	6.01e-05	8.59e-05	CcSEcCtD
Fondaparinux sodium—Nausea—Epirubicin—prostate cancer	5.83e-05	8.34e-05	CcSEcCtD
Fondaparinux sodium—Vomiting—Doxorubicin—prostate cancer	5.78e-05	8.26e-05	CcSEcCtD
Fondaparinux sodium—Rash—Doxorubicin—prostate cancer	5.73e-05	8.19e-05	CcSEcCtD
Fondaparinux sodium—Dermatitis—Doxorubicin—prostate cancer	5.73e-05	8.18e-05	CcSEcCtD
Fondaparinux sodium—Headache—Doxorubicin—prostate cancer	5.69e-05	8.13e-05	CcSEcCtD
Fondaparinux sodium—Nausea—Doxorubicin—prostate cancer	5.4e-05	7.71e-05	CcSEcCtD
